08:00 , Feb 22, 2016 |  BC Week In Review  |  Clinical News

BD FACSPresto Near-Patient CD4 Counter system regulatory update

FDA granted 510(k) clearance to Becton Dickinson’s BD FACSPresto system and BD FACSPresto CD4/Hb Cartridge to measure absolute and percentage results of CD4 T lymphocytes and hemoglobin concentration in blood samples from HIV/AIDS patients. Using...
07:00 , Oct 6, 2014 |  BC Week In Review  |  Clinical News

BD FACSPresto Near-Patient CD4 Counter system regulatory update

Becton Dickinson's BD Biosciences division said the World Health Organization (WHO) awarded prequalification to the company's BD FACSPresto Near-Patient CD4 Counter system to measure absolute and percentage results of CD4+ T lymphocytes and hemoglobin...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

Becton Dickinson sales and marketing update

Becton Dickinson's BD Biosciences segment launched BD FACSPresto Near Patient CD4 Counter system in countries that recognize CE Mark approval for measuring absolute and percentage results of CD4 T lymphocytes and hemoglobin concentration in blood...